Related Experiment Video
Updated: Sep 23, 2025

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Intravenous immunoglobulin in the management of refractory lupus profundus
Rajaie Namas1, Fatima A Abdulla2, Mohamed Elarabi1
1Division of Rheumatology, Department of Internal Medicine, 284697Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
Abstract:
Lupus profundus, often known as lupus panniculitis, is a rare form of persistent cutaneous lupus erythematosus. It usually manifests as painful plaques or nodules that can ulcerate and cause atrophy and scarring. It may respond to topical treatments and antimalarials, although treatment might be difficult at times, necessitating immunosuppressive medications. A 36-year-old woman from the United Arab Emirates presented with multiple painful disfiguring nodules involving the face and shoulders. The disfiguring skin nodules were resistant to systemic glucocorticoids, hydroxychloroquine, azathioprine, mycophenolate mofetil, and cyclosporine, but they significantly improved with monthly intravenous immunoglobulin over a 6-month period.
Related Concept Videos
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Venous Thrombosis III: Interprofessional Care
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Myocarditis IV: Nursing Management

